Creoptix Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 31

Employees

  • Latest Deal Type
  • M&A

Creoptix General Information

Description

Developer of biosensors designed to accelerate discovery by providing cutting-edge tools for molecular interaction analysis. The company's biosensors focus on next-generation bioanalytical instruments for drug discovery and life sciences for both industry and academic research, enabling life science researchers to benefit from versatile carboxyl-coupling for a range of molecules and software, which integrates assay setup and data evaluation in one tool.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Zugerstrasse 76
  • 8820 Wadenswil
  • Switzerland
Primary Industry
Discovery Tools (Healthcare)
Vertical(s)
Corporate Office
  • Zugerstrasse 76
  • 8820 Wadenswil
  • Switzerland

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Creoptix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 07-Jan-2022 Completed Generating Revenue
4. Later Stage VC (Series C) 30-Sep-2019 Completed Generating Revenue
3. Later Stage VC (Series B) 26-Jul-2017 Completed Generating Revenue
2. Early Stage VC (Series A) 20-Nov-2013 $3.3M $3.3M Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view Creoptix’s complete valuation and funding history, request access »

Creoptix Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C
Series C
Preferred A
Preferred Shares
Preferred Shares 4,338 $2.53 $2.53 1x $2.53 0.68%
Ordinary Shares 53,502 $22.73 $22.73 1x $22.73 8.35%
To view Creoptix’s complete cap table history, request access »

Creoptix Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of biosensors designed to accelerate discovery by providing cutting-edge tools for molecular interaction analy
Discovery Tools (Healthcare)
Wadenswil, Switzerland
31 As of 2022

Melbourn, United Kingdom
 

Pleasanton, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Creoptix Competitors (9)

One of Creoptix’s 9 competitors is SPT Labtech, a Private Equity-Backed company based in Melbourn, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
SPT Labtech Private Equity-Backed Melbourn, United Kingdom
Unchained Labs Private Equity-Backed Pleasanton, CA
Nanion Technologies Accelerator/Incubator Backed Munich, Germany
Standard BioTools Formerly VC-backed San Francisco, CA
Carterra Venture Capital-Backed Salt Lake City, UT
You’re viewing 5 of 9 competitors. Get the full list »

Creoptix Patents

Creoptix Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4172625-A1 A method for determining kinetic parameters of a reaction Active 26-Jun-2020
JP-2023531046-A Methods for determining kinetic parameters of reaction Active 26-Jun-2020
US-20230273202-A1 A method for determining kinetic parameters of a reaction Pending 26-Jun-2020
EP-4172625-B1 A method for determining kinetic parameters of a reaction Active 26-Jun-2020
JP-7672436-B2 Methods for determining the kinetic parameters of a reaction Active 26-Jun-2020 G01N33/557
To view Creoptix’s complete patent history, request access »

Creoptix Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Creoptix Former Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
Aargauische Kantonalbank Corporation Minority
EFI Lake Geneva Ventures Venture Capital Minority
EuroUS Ventures Venture Capital Minority
Fongit Seed Invest Venture Capital Minority
Massachusetts Biomedical Initiatives Accelerator/Incubator
You’re viewing 5 of 12 investors. Get the full list »

Creoptix FAQs

  • When was Creoptix founded?

    Creoptix was founded in 2009.

  • Where is Creoptix headquartered?

    Creoptix is headquartered in Wadenswil, Switzerland.

  • What is the size of Creoptix?

    Creoptix has 31 total employees.

  • What industry is Creoptix in?

    Creoptix’s primary industry is Discovery Tools (Healthcare).

  • Is Creoptix a private or public company?

    Creoptix is a Private company.

  • What is Creoptix’s current revenue?

    The current revenue for Creoptix is .

  • How much funding has Creoptix raised over time?

    Creoptix has raised $12.8M.

  • Who are Creoptix’s investors?

    Aargauische Kantonalbank, EFI Lake Geneva Ventures, EuroUS Ventures, Fongit Seed Invest, and Massachusetts Biomedical Initiatives are 5 of 12 investors who have invested in Creoptix.

  • Who are Creoptix’s competitors?

    SPT Labtech, Unchained Labs, Nanion Technologies, Standard BioTools, and Carterra are some of the 9 competitors of Creoptix.

  • When was Creoptix acquired?

    Creoptix was acquired on 07-Jan-2022.

  • Who acquired Creoptix?

    Creoptix was acquired by Malvern Panalytical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »